Evommune, Inc. vs. Eli Lilly & Co.
Evommune, Inc. and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| EVMN | LLY | |
|---|---|---|
| Market Cap | $244.25 million | $1.26 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| EVMN | LLY | |
|---|---|---|
| Dividend Yield | — | 0.49% |
EVMN and LLY split the dividend factors evenly.
Risk & Sentiment
| EVMN | LLY | |
|---|---|---|
| Short Interest | 0.28% | 1.29% |
EVMN leads on 1 of 1 risk & sentiment factors.
Dig deeper: EVMN overview, EVMN financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.